Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 813 results for "daiichi sankyo company"

Daiichi Sankyo Receives Approval for Additional Indications of...

Comments TOKYO, Sept. 26, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it received approval from the Ministry of Health, Labour and Welfare inJapan for LIXIANA® (JAN: Edoxaban Tosilate ... AndhraNews.net, 23 hours ago
Daiichi Sankyo adquiere Ambit Biosciences PR Newswire, 1 day ago
[x]  

20 images for daiichi sankyo company

4 Traders, 2 months ago
4 Traders, 3 months ago
Pharma Letter, 1 month ago
Pharma Letter, 1 month ago
companiesandmarkets.com, 3 months ago
TeleTrader.com, 4 months ago
Rediff.com, 5 months ago
Rediff.com, 5 months ago
The Freepress Journal, 5 months ago
Rediff.com, 5 months ago

Daiichi Sankyo acquires Amid Biosciences for USD410m

(MENAFN) Daiichi Sankyo Co., Japan's pharmaceutical firm, said it has reached an agreement to acquire US company Ambit Biosciences for USD410 million, QNA reported. The Japanese company said the move aims to establish its presence in the oncology ...
 MENAFN2 days ago Japan's Sankyo Acquires US Pharmaceutical Firm for $410 Million  Qatar News Agency1 day ago

AMBIT BIOSCIENCES : Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Daiichi Sankyo Company, Ltd.

NEW YORK, Sept. 29, 2014 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether the Board of Directors of Ambit Biosciences ("Ambit Biosciences" or the "Company") (NASDAQ: AMBI) breached its fiduciary duty to its shareholders in agreeing to ...
 4 Traders1 day ago Glancy Binkow & Goldberg LLP is Investigating Ambit Biosciences Corporation Board of Directors  Industrial Info Financials1 day ago SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Ambit Biosciences Corporation in Connection with the Sale of the Company -AMBI  Review Seeker10 hours ago Harwood Feffer LLP Announces Investigation Of Ambit Biosciences Corporation  TheStreet.com1 day ago
[x]  

Daiichi Sankyo Offers $315M Up Front to Get Ambit and Leukemia Drug

Japan's Daiichi Sankyo has agreed to acquire San Diego cancer drug developer Ambit Biosciences (NASDAQ: AMBI) for $315 million in cash, with additional milestone payments that could bring the total to $410 million. The transaction comes just over a ...
 Xconomy1 day ago DAIICHI SANKYO : to buy U.S. bio-firm to boost cancer drug development  4 Traders2 days ago Daiichi Sankyo bags leukemia drug in $410M Ambit buyout  FierceBiotech2 days ago Daiichi Sankyo to buy U.S. bio-firm to boost cancer drug development  Pharmacy Choice2 days ago

Midday Gainers From September 29 - Ambit Biosciences Corp, Dreamworks Animation Skg Inc And More

Ambit Biosciences Corp (NASDAQ: AMBI) +85% - The company formally announced that Daiichi Sankyo will acquire all of the outstanding common stock of Ambit Biosciences for $15 per share. Einstein Noah Restaurant Group, Inc. (NASDAQ: BAGL) +50% - The ...
 Benzinga.com1 day ago

AMBIT SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Buyout by Daiichi Sankyo

Company Website: http://www.powerstaylor.com DALLAS -- (Business Wire) Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating ...
 Stockwatch1 day ago

EQUITY ALERT: Rosen Law Firm Announces Investigation of Ambit Biosciences Corporation Concerning its Proposed Sale to Daiichi Sankyo Company, Ltd.

Company Website: http://rosenlegal.com/cases-381.html NEW YORK -- (Business Wire) The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of Ambit Biosciences Corporation (NASDAQ:AMBI) for possible ...
 Stockwatch15 hours ago Ambit Biosciences : EQUITY ALERT: Rosen Law Firm Announces Investigation of Ambit Biosciences Corporation Concerning its Proposed Sale to Daiichi Sankyo Company, Ltd.  4 Traders15 hours ago
[x]  

Daiichi Sankyo va acquérir Ambit Biosciences

-- Le composé chimique phare, le Quizartinib, va renforcer le portefeuille de traitements cancérologiques de Daiichi Sankyo TOKYO et SAN DIEGO , 29 septembre 2014 /PRNewswire/ -- Daiichi Sankyo Company, Ltd. (ci-après désignée Daiichi ...
 PR Newswire1 day ago

Why Ambit Biosciences (AMBI) Stock Is Soaring Today

NEW YORK (TheStreet) -- Shares of Ambit Biosciences (AMBI) Daiichi Sankyo cited Ambit's drug candidate quizartinib, which is in late-stage trials for the treatment of acute myeloid leukemia, as the primary reason for the purchase. The offer of $15 ...
 TheStreet.com1 day ago

Acute Coronary Syndrome - Current and Future Players: Amgen, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, GSK, Janssen Pharma, Merck, Pfizer & Sanofi

Research and Markets (http://www.researchandmarkets.com/research/lx7n7r/pharmapoint) has announced the addition of the "PharmaPoint: Acute Coronary Syndrome - Current and Future Players" report to their offering. The report is a vital source of ...
 Individual.com6 days ago Jay Feingold appointed CMO at ADC Therapeutics amid large-scale hiring drive  Pharma Letter1 day ago Anaplastic Thyroid Cancer Therapeutics Pipeline Review 2014 - 7 Companies & 11 Drug profiles  Individual.com1 week ago Research and Markets: Acute Coronary Syndrome - Current and Future Players: Amgen, AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, GSK, Janssen Pharma, Merck, Pfizer & Sanofi  Morningstar.com6 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less